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Abstract 
Purpose:  Breast cancer is the leading cause of cancer death among Latina women, with 
BRCA1/2 gene mutations accounting for a commensurate proportion of breast/ovarian 
cancer in Latina women as compared to non-Latina women.  Despite this statistic, it has 
been shown that Latino populations exhibit low awareness and use of genetic services 
and that they hold culturally-related beliefs which stigmatize cancer.  We hypothesized 
that a simple, culturally-tailored educational flier would improve genetics knowledge as 
well as decrease breast cancer-related stigma among Latina women in our sample.  
Method:  Two groups of Latina women (N = 19) were provided with a pre-survey, 
educational flier, and then post-survey to assess their knowledge of breast cancer-related 
genetics and their emotional status.  Qualitative responses regarding cancer-related 
perceptions were also gathered post-flier.  Participants included women both affected and 
unaffected by breast cancer and were surveyed from either a Spanish-language breast 
cancer support group in Orlando, FL or a Hispanic community health education seminar 
in Charleston, SC. The Wilcoxon signed-rank test was employed to analyze pre- and 
post-flier results.  The Repeated Measures ANOVA was used to assess emotional status 
as a function of cancer diagnosis.  Qualitative data was coded and analyzed using 
grounded theory methods. Results: None of the women showed significant gains in 
knowledge related to breast cancer after viewing the educational flier. All women 
demonstrated significant increases in anxiety between baseline emotional status and 
emotional status related to either a real or hypothetical diagnosis of cancer.  Unaffected 
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participants showed higher anxiety means overall.  Qualitative analysis identified four 
major themes: (1) cancer means fear, death, and family isolation; (2) cancer is difficult to 
explain; (3) perceived causes of cancer; and (4) attitudes of hope.  Conclusions:  We 
showed that either a real or hypothetical diagnosis of breast cancer increases anxiety 
above that of baseline emotional status among our sample population of Latina women 
who attend health-focused support groups.  We theorize that a refined version of the flier 
may be more effective as part of a larger educational platform, in which participants are 
provided with expanded information and encouraged to participate in cancer and 
genetics-centered conversation. We hope future research endeavors will build upon the 
utility of effective educational materials to improve genetic counseling referrals and 
genetic-medicine healthcare among this growing population.  
 
Keywords: Cancer genetics, breast cancer, BRCA1, BRCA2, genetic testing, 
stigma, Latina, Spanish 
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Chapter 1:  Background 
1.1.The Current State of Breast Cancer and Availability of BRCA Gene Testing 
In 2010, cancer became the leading cause of death worldwide (Neal, Beckjord, 
Rechis, Schaeffer, Berno, & Duchover, 2011).   Moreover, breast cancer is the most 
commonly diagnosed cancer among women in the world according to Phillips and 
Cohen (2011).  The authors maintain that breast cancer is the leading cause of cancer-
related deaths among women 20-59 years of age in high-income countries, and it is 
the second leading cause of cancer death for women in the United States.  In 
perspective, the authors claim that despite the mortality rates due to breast cancer in 
the United States, half of all breast cancer cases occur in economically developing 
countries.    
Guidelines in the United States advise women age 40 and above to receive 
yearly mammograms, which is the prevailing method for early breast cancer 
detection.  Although multiple organizations have put forth respective screening 
protocols, those released by the American Cancer Society (ACS) are frequently cited.  
The ACS recommends that average-risk asymptomatic women age 40 and above 
receive annual clinical breast examinations and engage in optional monthly self-breast 
examinations (Phillips & Cohen, 2011).  The authors expand on screening rationale: 
“To date, no established preventative measures exist for breast cancer; therefore, the 
greatest hope for reducing breast cancer mortality and improving breast cancer 
survival lies in early detection and prompt follow-up treatment” (p. 239). 
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According to Gold and Carbone (2010), scientists estimate that between 5% and 
10% of breast cancers are hereditary, meaning that the cancer is caused by a defective 
gene in the body that can be passed down through generations.  The authors categorize 
hereditary breast cancer as being suspected in individuals with a positive family history 
for breast and ovarian cancer, families in which males present with breast cancer, breast 
cancer appearing before the age of 40, and/or bilateral or multifocal breast cancer.  The 
remaining 90% to 95% of cases of breast cancer is considered sporadic or familial, 
suggesting an association with environmental influences and/or unknown genetic 
determinants (Yeomans Kinney, Gammon, Coxworth, Simonson, & Arce-Laretta, 2010).   
Competition among institutions around the world led to the discovery and 
sequencing of the BRCA1 and BRCA2 genes in the early 1990s.  Mutations within the 
BRCA1 and BRCA2 genes are estimated to contribute to up to 50% of the hereditary 
breast cancer category (van der Groep, van der Wall, & van Diest, 2011; Walsh & King, 
2007; Meindl, Ditsch, Kast, Rhiem, & Schmutzler, 2011). Research on these genes 
showed how their products, when working correctly, act as tumor suppressing proteins.  
Conversely, mutations, or changes in the chemical sequence of these genes, can confer an 
increased lifetime risk of 40% to 85% to develop breast cancer and a lifetime risk of 16% 
to 40% to develop ovarian cancer.   The risk is 12.7% and 1.4%, respectively, for the 
general population (Antoniou et al., 2003; Hopper et al., 1999; Chen & Parmigiani, 2007; 
Gold & Carbone, 2010).  
Gold and Carbone (2010) recounted how with better understanding of the location 
and sequence of the BRCA1/2 genes, laboratories were able to develop diagnostic testing, 
thus capitalizing on the opportunity for preventive management of hereditary breast 
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cancer.  Myriad Genetics, Inc., and its subsidiary, Myriad Genetics Laboratories, Inc., 
were granted a United States patent in 1997 covering 47 BRCA1 gene mutations.  BRCA2 
mutation patents were granted to Myriad Genetics in 1998 and 2000.  The Utah-based 
company currently has prominence over the commercialization of genetic testing for 
mutations in these hereditary breast cancer genes, and diagnostic testing in the United 
States is thus ordered through their laboratory.  As of 2010, Myriad Genetics has curated 
a database of the results of over 400,000 samples, including known deleterious mutations 
and numerous polymorphisms. 
The American Society of Clinical Oncology (ASCO) recommends that cancer 
predisposition testing be offered only when (1) the person has a strong family history of 
cancer (or diagnoses at very early ages), (2) the test can be adequately interpreted, and (3) 
the results will influence the medical management of the patient and family (Gold & 
Carbone, 2010).  Evidence suggests that surveillance, chemoprevention, and prophylactic 
surgical interventions are all beneficial options for individuals with a deleterious 
BRCA1/2 mutation.  The ACS advises that women at an increased risk due to family 
history talk with their physicians about the benefits and limitations of starting 
mammography screening earlier (before the age of 40), as well as the benefits of 
additional examinations such as magnetic resonance imaging (MRI) and ultrasonography.  
The ACS also acknowledges the utility of genetic testing (“Genetic Testing: What You 
Need to Know,” 2013) and includes online references to guide individuals who may be 
good candidates for the test.  
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1.2.The Genetic Counseling Profession: Support in Navigating the Genetic Testing 
Process 
According to a 2006 task report by Resta, Biesecker, Bennett, Blum, Hahn, Strecker, 
and Williams, genetic counselors are appropriate referrals in order to facilitate the genetic 
and psychosocial implications of familial disease.  The authors describe genetic 
counselors as healthcare experts with specialized graduate degrees and experience in the 
areas of medical genetics and counseling.  The process of genetic counseling involves 
helping people understand and adapt to the medical, psychological, and hereditary 
implications of genetic contributions to disease.   According to Rolnick et al. (2011), 
identification of high risk individuals by family history may indicate an inherited genetic 
susceptibility, and through genetic counseling, patients can become more aware of the 
use of effective strategies for disease prevention and early detection.  
A subset of genetic counselors specialize in the role of cancer genetic counseling.  
The primary goal of this field is to manage patient concerns regarding the occurrence or 
risk of a genetically inherited cancer in the family and to assist in the genetic testing 
process if desired by the patient (Resta et al., 2006; “Cancer Genetics,” n.d.).  The 
National Comprehensive Cancer Network (NCCN) states that “women at high risk would 
benefit from genetic counseling that helps patients or family members make informed 
decisions about genetic testing and enhances selection of early cancer detection or risk-
reduction strategies” (Kinney et al., 2010, p.2).   
Genetic counselors are able to provide patients with a professional evaluation of 
genetic test results as well as discussion regarding health and management implications 
(Gammon et al., 2011).  According to Glenn, Chawla, and Bastani (2012), genetic 
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counseling is advised prior to testing for BRCA1/2 in order to “asses risk-level, explain 
the risks and benefits of testing, and provide psychological support and assistance in 
decision-making” (p. 267). The authors also described the influence of counseling in 
terms of follow-up care, including providing support to navigate options of surgery, 
chemoprevention, and increased screening.  Importantly, identification of the gene 
change in one family member is often informative for other family members who might 
be at risk.  These at-risk individuals might then decide to pursue genetic testing for their 
own benefit.  In effect, genetic counseling is sometimes able to provide risk reduction 
strategies for an entire, multi-generational family (Glenn, Chawla, & Bastani, 2012).  
Moreover, Rolnick et al. (2011) showed that genetic counseling with high risk individuals 
has been reported to increase knowledge and decrease anxiety regarding the genetic 
testing process. 
 Myriad Genetics also acknowledges that “genetic testing indicates the probability 
rather than the certainty of having a disease, and the results of the tests can be difficult 
not only for the average patient but also for the average doctor to interpret” (Gold & 
Carbone, 2010, p. 14).  Vos et al. (2010) supported this notion in their explanation of how 
a pathogenic mutation, or positive result, implies increased risk to develop cancer.  They 
described that this increased risk then presumes increased options for risk-reducing 
strategies, but also for potential feelings of distress.  The authors continued to explain 
how an uninformative, or negative, result implies that “no mutation was found but that 
the counselee’s pedigree suggests that cancer is [still] likely to be heritable in this family” 
(p. 240). In other words, although no known BRCA1/2 mutation was found, the individual 
remains at an increased risk for breast cancer.  The authors concluded by explaining the 
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potential to find a variant of uncertain clinical significance (VUS).  This type of result 
implies that a genetic mutation has been found; however, its current clinical significance 
is unknown, such that the variant could be either pathogenic (disease-causing) or benign 
(not disease-causing).  Vos et al. (2010) remarked that a VUS result often confers high 
levels of uncertainty and relatively high distress in the patient. 
Psychological implications of genetic testing must also be considered. Carriers of 
a mutated gene may grapple with the burden of guilt in regard to passing on the mutation 
and potentially being the cause of his or her children and grandchildren to be at increased 
risk of developing disease (Weil, 2000).  Gibbon (2007) and Hallowell (1999) expanded 
on this concept by acknowledging the significance of tension that can result between an 
individual’s investment in “what is perceived as preventative health” and the 
consequential “predictive information for the family” (as cited in Gibbon, 2011, p. 1784).  
Gibbon also cited Konrad (2005) to explain that genetic knowledge can unfold unevenly 
in families and encroach upon kin’s ‘rights to know’ or ‘not to know,’ meaning that the 
results of one family member’s test could potentially provide health information for other 
family members, whether or not those individuals are interested in knowing.       
The genetic counseling process also guides mutation-positive patients through 
inquiries about potential health insurance discrimination and financial implications, 
including coverage for preventive measures.  Conversely, patients who receive a negative 
test result run the risk of psychological harm due to false reassurances (the belief that he 
or she is now immune from the disease) (Gold & Carbone, 2010).  This occasionally 
complex topic of false reassurance can also be clarified through the counseling process.   
In this way, genetic counseling is opportune in order to navigate the logistic, educational, 
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and emotional adjustments that may be caused by the results of genetic testing (Resta et 
al., 2006).  
1.3 The United States Latino Population and Their Awareness of Genetic Testing 
Latino is the Latin word for “Spanish,” and is also used as a prefix for the South 
American continent, or Latin America (Fisher, 1996).  The term Latinos/Latinas is often 
reported as a single category, although it is representative of “multiple subgroups from 
various countries and cultural backgrounds” (Sudarsan, Jandorf, & Erwin, 2010, p. 194).  
This ethnically and racially diverse group of people have roots in Central or South 
America, the Caribbean, and Spain (Yeomans Kinney et al., 2010).  Fisher (1996) 
reflected that while some consider Latino to be a better representation of Spanish, 
indigenous, and African cultures that are now part of Latin America, the term is also 
applied as a generic ethnic label by the American Public Health Association (Fisher, 
1996).  Latinos (noting the –os suffix) refers to both males and females as a group, 
whereas Latinas is reserved for only female representation.      
Importantly, Latinos are currently the fastest growing minority population in the 
United States (Gammon et al., 2011).   According to Yeomans Kinney et al. (2010), more 
than 37 million Latinos are currently living in the United States, and Latinos are 
predicted to comprise 25% of the United States population by the year 2050.  Although 
ancestry varies, Mexicans represent the largest percentage of the Latino population 
(54.1% in 2010), followed by Puerto Ricans, Cubans, Central Americans (other than 
Mexicans), South Americans, Dominicans, Spaniards, and those who consider 
themselves of “general Hispanic ancestry” (Cokkinides, Bandi, Siegel, & Jamal, 2012; 
U.S. Census Bureau, 2010).    
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According to Yeomans Kinney et al. (2010), Latino individuals exhibit low 
awareness and use of genetic services.  The low uptake is especially concerning as breast 
cancer is the most frequently diagnosed cancer and leading cause of cancer death among 
Latina women, according to the same authors.  Although overall incidence rates of breast 
cancer have been shown to be lower among Latina populations than among white 
women, Latinas are 22% more likely to die of breast cancer within five years after 
diagnosis (Sussner, Thompson, Valdimarsdottir, Redd, & Jandorf, 2008).  Moreover, 
Yeoman Kinney et al. (2010) showed that these women are more likely to be diagnosed 
at younger ages and with the disease having already progressed to later stages.  Sussner et 
al. (2008) found that these factors still hold true even when controlling for income, 
education, and method of detection.     
Literature has similarly suggested that Latina women are less likely to use 
preventive services such as mammograms and self-breast exams (Yeomans Kinney et al., 
2010).   Studies from 2005 found that only 59.6% of Latina women aged 40 and above 
had undergone a mammography exam within the past 2 years, as compared to 68.1% of 
non-Latina whites.   Part of the lower incidence of breast-cancer among Latinas, as well 
as higher mortality rates, might simply relate to absence of diagnosis due to low 
mammography utilization (Sudarsan, Jandorf, & Erwin, 2010).   
Reports from Myriad Genetics have shown that of all women who opted for 
BRCA testing between 1996 and 2007, only 4% were Latina (Sussner et al., 2008).  
Despite this statistic, evidence has suggested that BRCA1/2 mutations account for as 
many incidences of breast and ovarian cancer in Latina women as compared to non-
Latina women.  A study by Myriad Genetic Laboratories, Inc. analyzed over 17,000 
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women at high-risk for breast cancer.  Results found that 31.3% of Latin 
American/Caribbean women tested positive for a BRCA mutation as compared to 23.3% 
of women of Western/Northern Europe descent (“Myriad Genetic Laboratories,” 2013). 
More recent data has reported a subset of BRCA mutations that is more prevalent among 
the Latinos, including a higher prevalence of ‘large rearrangement mutations’ within the 
BRCA genes. (Mullineaux et al, 2003; Voelker, 2009; Myriad Genetic Laboratories, 
2013; Gammon et al., 2011).   
A 2012 study by Glenn, Chawla, and Bastani (2012) investigated barriers to 
genetic testing for breast cancer risk among ethnic minority women.  The authors 
attributed underuse of genetic testing among these women to lack of knowledge and 
awareness, as well as other nuanced cultural and language factors.  They further 
explained that low levels of awareness for genetic testing were generally observed across 
all minority women, including those of Latina ethnicity.  Additionally, a 2000 analysis 
performed by the National Health Information Survey (NHIS) in East Harlem (New York 
City) found that only 20.6% of Latinos reported having heard of genetic testing for 
cancer risk, as compared to 32.9% of African Americans and 49.9% of whites (Sussner et 
al., 2008).     
1.4 Latino Cultural Influences regarding Healthcare and Genetics  
According to Fisher (1996), the Latino term curanderismo is derived from the 
Spanish word curar, meaning ‘to heal.’ The term applies to the treatment of a variety of 
illnesses using a combination of psychosocial interventions, herbs, potions, and religion.   
In more modern times, curanderismo incorporates modern psychology and scientific 
medicine.  The belief system commonly links disease state to one of three causes: natural 
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and supernatural forces; imbalances of heat and cold; and emotion.  Given this backdrop 
of beliefs, Fisher remarks that many Latino families might even consult a folk healer 
before considering an appointment with a medical doctor, adding that the impersonality 
of Western medical practice can present an additional deterrent.   
Gibbon (2011) studied the understanding of predictive genetics regarding breast 
cancer among Cuban women.  She noted that many women described the cause of the 
disease as a ‘physical blow’ or golpe that was significant enough to cause cancer.  It was 
implied among the women that the breast was a zona delicada (delicate, sensitive body 
area) that was therefore more susceptible to injury.  The author proposed that this concept 
arose from a sense that the disease strikes to or against the body from outside the body 
(pollution, dietary deficit, etc.), rather than being generated within the body (Gibbon, 
2011).   This notion of golpe – or outside influence triggering breast cancer – is also not 
uncommon among Latinos in the United States or Mexico, and in fact, might be similarly 
perceived as the English equivalent to stress. Finkler (1991) has suggested that the 
golpe/stress creates connection between disorder in the body and state of disease and 
concurrently points to a source of illness within one’s life history (as cited in Gibbon, 
2011).   
According to a study by Gibbon (2011), a relative unavailability of predictive 
genetics (including BRCA testing) exists in Cuba.  Lack of media coverage and 
discussion regarding the genetics of breast cancer, as well as general lack of breast cancer 
activism, has been observed in this population.  The effect is that few women in Cuba 
have heard of the BRCA genes, and women in the study therefore had no point of 
reference to discuss genes or genetic factors.  Those who had heard of los genes were still 
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unable to engage in meaningful discussion, and instead used vague concepts such as 
‘something being transmitted in the blood’ (Gibbon, 2011).   
A chapter from Race, Ethnicity, and Health (LaVeist & Isaac, 2013), examined 
the interplay between acculturation and Latino health status in the United States.  The 
authors loosely defined acculturation as “Westernization,” “urbanization,” 
“Americanization,” and “modernization,” among more formal definitions such as the 
“phenomenon that results as groups of individuals having different cultures come into 
continuous first-hand contact, with subsequent changes in the original cultural patterns of 
either or both groups” (Redfield,, Linton, & Herskovits, 1936, p.149 as cited in LaVesit & 
Isaac, 2013).   
Interestingly, the authors found that health outcomes among Latinos in the United 
States showed substantial heterogeneity as well as variations across country of origin.  
Negative effects of acculturation (poorer health) were shown in domains of nutrition, 
exercise, drug use, and smoking.  However, they found positive effects (improved health) 
in domains of general health care use, use of preventive strategies, insurance acquisition, 
and cervical/breast screening. The authors concluded that health outcomes as a function 
of acculturation are “very complex and not well understood” (LaVeist & Isaac, 2012, p. 
225).  
Cokkinides et al. (2012) similarly investigated health domains of United States 
Latino adults.  Authors showed that these individuals have lower levels of mammography 
use, colorectal screening, and Pap tests compared to non-Hispanic/Latino whites in the 
United States.  However, the authors also showed differences in risk factors according to 
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country of origin and age group, and therefore cautioned that these variables be 
considered in cancer control planning.   
A 2012 study by Sussner, Jandorf, Thompson, Heiddis, and Valdimarsdottir more 
closely examined the result of acculturation on both barriers and facilitators to BRCA 
genetic counseling among at-risk Latinas in New York City.  Participants in their sample 
population showed a mean acculturation level of 2.4 on a 1-4 scale using Marin and 
Gamba’s bidirectional acculturation scale for Hispanics.  Using this number and 
demographic data, researchers described their sample group of women as being of fairly 
high acculturation status.  Results showed that “more than half of participants had heard 
or read ‘almost nothing’ or ‘relatively little’ about genetic counseling for inherited 
disease and for cancer” (p. 6).   
Glenn, Chawla, and Bastani (2012) provided another context for understanding 
low uptake for genetic services among Latinos.  The authors showed that Latina women 
were especially inclined to prioritize family health needs above their own personal 
healthcare demands.   Latina study participants described the traditional female role as 
the reason for delaying her own health care in favor of the overarching needs of the 
family.  In turn, this hierarchy has rendered the women less aware and accepting of 
preventive health services, including awareness and knowledge of genetic testing and 
genetic counseling (Glenn, Chawla, & Bastani, 2012).  One woman provided this 
illustration: 
I think we [Latinas] tend to be more concerned about…family loyalty [vs personal 
health care needs]…we become martyrs and we will take the pain and 
suffering…culturally this is what women do, it is something ingrained in your 
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culture in your upbringing…You [women] don’t burden the family unnecessary. 
(p. 270) 
1.5 Unique Barriers Affecting United States Latinos in their Access to Genetics 
Healthcare Services 
As evidenced by Rolnick et al. (2011), the genetic counseling community 
recognizes that there are particular obstacles that confront their patients regarding use of 
and access to cancer genetic services.  The study found that genetic professionals 
considered the top “perceived patient barriers to seeking genetic counseling after referral” 
(p. 314) to include any of the following factors: risk evaluation viewed as a non-priority, 
concerns about impact on insurability, distance to appointments, lack of insurance, lack 
of patient/provider knowledge about the value of genetic counseling, discouragement by 
family members, and fear.   
In regard to Latino-specific barriers in the United States, a study by White, 
Garces, Bandura, McGuire, & Scarinci (2012) identified obstacles that included lack of 
health insurance, limited English proficiency, recent immigration status, and perceptions 
such as procrastination, embarrassment, and fear.  Results of a research study by Walton, 
Brandt, & Hilfinger Messias (“Latina Initiative Against Cancer,” 2012) has suggested 
that the most common regional barriers to breast/cervical cancer screening for Latina 
women in the state of South Carolina include lack of access to cancer screening services, 
fear of not having an interpreter, and miscommunications with the clinic.  The combined 
effect of these deterrents has resulted in that Latinos engage in less frequent use of 
preventive services, engage in increased use of hospital emergency rooms, and exhibit 
less satisfaction with their healthcare (Hispanic Health Initiative [HHI], n.d.). 
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It has been demonstrated that a substantial proportion of the Latino population in 
the United States tends to lack a regular healthcare provider, a specific place of care, or a 
dependable form of transportation to access healthcare services (Sudarsan, Jandorf, & 
Erwin, 2010).  Lack of quality medical care is exacerbated by the fact that nearly one-
third of American Latinos lack health insurance (Yeomans Kinney et al., 2010).  
According to Chandler et al. (2012), “Latina immigrants, and undocumented Latinas […] 
are more likely to be uninsured than their documented counterparts” (p.E24).  In effect, 
this group of women who lack insurance are at heightened risk for poor health outcomes 
and increased burden from chronic disease. These women are also more likely to express 
“a great deal of dissatisfaction” with the care that they do receive (Chandler et al., 2012, 
p. E25).   
In addition to not having insurance, a 2012 study by Glenn, Chawla, and Bastani 
described issues confronting Latina women in regard to insurance discrimination.  One 
woman stated, “I am already worried about it.  I can’t get insurance…I have tried to get 
insurance…I have been looking for ten years…It’s already a concern…and yeah!  You 
are discriminated [against!].  The people [who] need it the most can’t get it” (p. 271).  
The authors concluded that this form of discrimination functions as a barrier to genetic 
testing and additionally influences decision-making options after testing.  
To understand the effect of managing breast cancer without insurance coverage 
(or without adequate insurance coverage), a 2011 study by Phllips and Cohen explored 
the healthcare implications for African American women, another minority population at 
high risk for breast cancer mortality.  One woman described the high cost of surveillance 
care for high-risk status in this way, “I’ve had two MRIs, which one was $5,000 and one 
15 
 
was $2,000.  My insurance doesn’t pay it at all…They don’t pay it unless you have been 
diagnosed with cancer…so that’s why I haven’t had another one” (p. 243). 
Chandler et al. (2012) theorized that United States discrimination of Mexican 
immigrant women creates a unique form of stigmatization.  The authors argued that as 
“women lack recognition of their essential humanity [due to their undocumented status]” 
(p. E33), power inequalities are worsened between patients and healthcare providers.  
This may be exacerbated by disparities in communication skills. In this regard, women 
feel stigmatized primarily as immigrants and secondarily as cancer patients; they are 
therefore increasingly reluctant to seek appropriate care (Chandler et al., 2012).  
 According to Escarce and Kapur (2006), language proficiencies exert substantial 
influences on patients’ experiences with healthcare providers, and information provision 
has been shown to be preferred in patients’ favored language and with access to qualified, 
professional interpreters (U.S. Department of Health and Human Services, 2001).  When 
language barriers exist between patient and provider, patients have been more inclined to 
decrease their use of primary care, increase use of emergency department care, and 
receive inadequate follow-up.  This  phenomenon is exacerbated by the fact that the 
United States healthcare system is largely geared toward serving English speakers and 
there is yet to be a corresponding increase in Latino healthcare workers to match the 
rapidly increasing Latino population (Escarce & Kapur, 2006; Timmins, 2002;  Peterson-
Iyer, 2008). 
1.6 Stigmatization of Cancer: Shame, Fear, and Silence 
In addition to the discussed influences in the decision to engage in genetic testing 
and counseling among Latina women, a particularly striking barrier is the emotions of 
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fear or shame.  In fact, the literature has documented that cancer-associated stigma is 
prevalent among Latinos.  ‘Stigma’ is described by the LIVESTRONG Foundation (The 
Lance Armstrong Foundation) as “the perception of the person affected by cancer as 
differing from the norm in a negative or undesirable way” (Neal et al., 2011, p. 3).  This 
definition of stigma therefore cultivates risk for self-induced inequity of medical care, 
loss of status, rejection, isolation, and failure to adopt risk-reducing strategies such as 
screening.  
 Gibbon (2011) noted the inherent link between understanding of disease and the 
“cultural meanings that may be linked to it” (p. 1785).  This author theorized that the 
concept of personhood (or identity) is associated with multiple variables, such as kin, 
family, and/or citizenship.  These variables extend to an individual’s sense of moral 
values, spirituality, and religion, which are then further interwoven into the larger context 
of institutional cultures or state provisions.  In total, these varying “pulls” on personhood 
can affect healthcare and may “influence, facilitate, or impede” biological understanding 
or uptake of new technologies (Gibbon, 2011, p. 1785).   
According to Gregg’s 2011 investigation of the stigmatization of cervical cancer 
among Brazilian women, the term stigma is a “discrediting attribute, an undesired 
differentness from social expectations” (p. 73).  In effect, stigmatized women – or cancer-
burdened women – may encounter anxiety relevant to their “deformed bodies” as well as 
“exclusion from moral community” (p. 73). Gregg (2011) merged these descriptions into 
what she considers a relatively ignored interplay between power roles and being 
stigmatized.  She stated that recent theorists have implied that “for stigmatization to 
occur, power must be exercised” (p. 73). Although the result is often discrimination 
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resistance, Gregg found the opposite effect within this population of Brazilian women, 
which was actually to perpetuate and maintain the stigma in order to preserve the 
continuity of community order and values.  This example demonstrates that one effect of 
stigmatization may actually be the acceptance of discrimination in order to concede to 
condemning values in one’s society and not create turmoil (Gregg, 2011). 
Yeoman Kinney et al. (2011) found that the word cancer evoked the following 
descriptors among Latinos: pain, suffering, sadness, death, worry, fear, anger, and 
agony.  Participants assumed that cancer was synonymous with death and that there was 
“nothing that one can do about it” (p. 107) or that it was simply “God’s will” (p. 111).  
The same study noted that participants described cancer as a “cultural taboo” (p. 112), 
something that might be contagious or shameful. Other participants expressed 
embarrassment and modesty as significant barriers to detection and risk-reduction 
services.  Gregg (2011) noted that the Brazilian women in her population would not talk 
openly about their disease with friends or neighbors. Community doctors in Brazil 
commonly referred to the disease only as ‘inflammation’ or ‘wound,’ which were applied 
as euphemisms for death.  In Cuba, the indirect terms el cangrejo, ‘the crab, is sometimes 
used to describe the disease, as well as simply “problemas con las mamas (problems of 
the breast)” (Gibbon, 2011, p. 1790).   
It is noteworthy that many Latino countries of origin do not have similar concepts 
of “biological citizenship” as those in the United States/United Kingdom where 
communities and cultures are tied to strong breast cancer activism movements with 
emphasis on detection, prevention, and awareness (Gibbon, 2011, p. 1790).   In 2007, 
LIVESTRONG launched a global cancer research study to empower individuals affected 
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by cancer and to address the pervasive problem of stigma in communities worldwide.  
Latin American countries that were included in the study were Mexico and Argentina.  
Information was gathered through a global media audit, public opinion research, and 
semi-structured interviews.  Recurrent  sentiments emerged such as little or no control 
over risk, lack of a cure, fear of death from cancer, and lack of knowledge about how and 
where to screen for cancer.   Results showed that stigma produced a silencing effect that 
opposed cancer risk-reducing behaviors or the likelihood to seek out supportive services.  
They found that cancer continues to “carry a significant amount of stigma; however, there 
are opportunities to capitalize upon shifting perceptions and positive change” (Neal et al., 
2011, p. 1).  They further concluded that many people still feel uninformed, that people 
want information, and that communication is critical in efforts to reduce cancer-related 
stigma and associated burden of disease.  
Due to the cultural silence of the disease, Latinos may be more reluctant to share 
family history of cancer.  This concept that “not telling a relative [about a diagnosis] is 
the best course of action” confers an additional deterrent to genetic counseling services 
(Yeomans Kinney et al., 2010; Gibbon, 2011, p. 1791).   Depending on country and 
culture of origin, traditions of non-disclosure and paternalism render it particularly 
difficult for genetic healthcare providers to elicit complete and accurate family histories, 
navigate family relationships, or provide appropriate care-giving or preventive 
suggestions (Gibbon, 2011).  The discontinuity in family pedigrees, as well as the silence 
and perceived stigmatization, prevents open discussion, meaningful interpretation of 
genetic risk, and possible interventions to increase awareness and decrease morbidity. 
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1.7 The Importance of Culturally and Linguistically Tailored Health Interventions 
Importantly, the growing United States Latino population is uncovering the reality 
that “cultural norms and health beliefs of the Spanish-speaking population are not well 
understood by healthcare providers” (“PASOs,” n.d.).  To manage this circumstance, 
research has suggested the importance of tailored interventions to reflect community 
priorities and cultures (Sudarsan, Jandorf, & Erwin, 2010).  Walton, Brandt, and Messias 
(2009) maintained that health education materials should be “culture and language 
appropriate” with information presented in a culturally precise framework, and with 
context at “no higher than a fifth grade reading level.” In addition, Latino-specific risk 
factors – including lower screening usage – should be recognized and considered in 
clinical settings and “for cancer control planning” (Cokkinides et al., 2012, p. 353). 
Yeomans Kinney et al. (2010) explored effective education methods and 
preferences among first or second generation Latinos living in the United States.  
Participant suggestions included reduction in the “level of technical detail” (p. 112) with 
technical information presented “clearly and succinctly” (p. 112), as well as easy-to-
interpret materials with simple words.  Other suggestions included use of entertainment 
forms of education (such as through telenovelas) or direct dissemination of materials 
through schools and churches (Yeomans Kinney et al., 2010).  Cokkinides et al. (2012) 
bolstered this suggestion by adding that “educational campaigns [to prevent cancer] 
should consider using multiple media, including television, radio, and newspapers and 
magazines, in both English and Spanish, to expand their reach to diverse Hispanic/Latino 
communities” (p. 361). 
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To add merit to the suggestion for decreased technical and scientific jargon, Saley 
et al. (2010) explored genetic perceptions of hereditary causes of cancer and illness 
among Arabic-Australians.  This population similarly contends with fears of 
stigmatization and fatalistic beliefs related to cancer.  Study results showed that 
participants were less likely to use the more scientific word gene, and more likely to 
describe genetics as inherited blood, in the family, get it through a parent, and strong or 
weak blood.   In similar fashion, Gibbon’s study (2011) investigating Cuban women with 
breast cancer found that there was better understanding when genetic risk was re-phrased 
in terms of hereditary factors, such as la herencia, (family history) and la salud or las 
enfermedades de los antecedents/ancestros (health or illness of family members).     
Rosal et al. (2004) explored education preferences of Latinos with low-literacy 
levels regarding diabetes education.  When presented with a one-page brochure and small 
educational poster, participants seemed to like the straightforwardness of the educational 
message and of the simplicity of the brochure.  They also showed enthusiasm for graphic 
representation of significant concepts.  The authors recommended the use of repetitive 
messages to solidify main points and to encourage information digestion.   
White et al. (2012) investigated the promotion and effectiveness of breast and 
cervical cancer screening for Latina immigrants.  Results demonstrated that educational 
approaches were most effective when tailored to address the cultural concerns 
surrounding screening and suggested that efforts should involve trusted social 
connections within the community.  The authors also recommended that outreach include 
Spanish-language announcements to call women to action regarding screening 
appointments.  However, they concluded that further research is necessary in order to 
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better understand barriers [to screening] and to more appropriately develop educational 
messages.  Walton, Brandt, and Messias (2009) suggested similar proposals, maintaining 
that “interaction with lay health workers [such as promotoras, the Spanish term for ‘lay 
health workers’]” is a crucial element in increasing adherence to cancer screening 
guidelines.  
1.8 Latinos Show High Level of Interest in Genetic Testing, Despite Barriers 
Published literature suggests that Latinos maintain a high level of interest in 
genetic testing for breast cancer susceptibility, despite apparent barriers to services and 
the need for improved educational interventions.  Gammon et al. (2010) observed that 
although 83% of Latino participants knew “almost nothing or relatively little [about 
genetic testing for breast cancer risk]” (p. 626), 81% of participants were interested in the 
topic.  An article by Sussner et al. (2008) suggested that “lack of knowledge may, in 
effect, drive interest level” (p. 69).  
According to Glenn, Chawla, and Bastani (2012), minority women in the United 
States have expressed interest in pursuing counseling and testing for three overarching 
reasons: to provide information to their families, to inform their own health, and for the 
benefit of society and scientific research.  One Hispanic woman from this same 2012 
study expressed her interest in genetic testing: “…for prevention and to know what to do 
in case it would happen to me or…to any of my relatives or future generations” (p. 271).  
Another Hispanic woman reported that her biggest obstacle in receiving genetic testing 
was simply a lack of information available, despite her being “diligent in keeping up with 
[her] health” (Glenn, Chawla, & Bastani, 2012, p. 271). 
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1.9 Implications for Improved Knowledge and Health  
The importance of this study is in its recognition for enhanced and informed decision 
making among Latinas with familial breast cancer.  While studies have implicated 
educational preferences for Latino populations, we currently do not know of any research 
conducted that has examined the effectiveness of a simple educational module with 
regard to breast cancer genetics.   
We hypothesize that a straightforward, targeted educational flier will significantly 
improve genetics knowledge and understanding among Latina women in our sample as 
well as reduce breast cancer-related stigma. Our data will therefore measure pre- and 
post-flier trends in knowledge/understanding and perceptions of stigmatization among 
this population.  We secondarily believe that these outcomes will help to improve current 
educational materials for these women as well as increase the current dissemination of 
such materials.  We recognize that an effective paper flier may become one fundamental 
element in a larger and more encompassing educational campaign that includes muti-
media outlets. 
The objectives of this study include the following:  
• Assess the effectiveness of a simple educational flier on the understanding of 
genetics knowledge among Latina women. 
• Analyze immediate emotional responses regarding breast cancer stigma. 
•  Improve educational materials about the genetics of breast cancer intended 
for use with Latino populations. 
• Promote improved health through enhanced understanding and empowerment 
regarding hereditary breast cancer. 
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We hope to find increased understanding of genetics in concert with reduction of 
cancer-related stigma among our sample population of Latina women in Florida and 
South Carolina.  We expect these results to stem directly from an educational flier 
tailored to the educational preferences of this cultural group. 
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Chapter 2: Manuscript 
Perceptions of Breast Cancer-related Stigma and Genetic Knowledge among  
Latina Women:  
el mejor entendimiento del miedo.1  
 
                                                      
1
 Cognetti, J.M., Walker, P., Ordonez, J., & Smithwick-Leone, J. To be submitted to Journal of Genetic 
Counseling. 
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2.1 Abstract  
Purpose:  Breast cancer is the leading cause of cancer death among Latina women, with 
BRCA1/2 gene mutations accounting for a commensurate proportion of breast/ovarian 
cancer in Latina women as compared to non-Latina women.  Despite this statistic, it has 
been shown that Latino populations exhibit low awareness and use of genetic services 
and that they hold culturally-related beliefs which stigmatize cancer.  We hypothesized 
that a simple, culturally-tailored educational flier would improve genetics knowledge as 
well as decrease breast cancer-related stigma among Latina women in our sample.  
Method:  Two groups of Latina women (N = 19) were provided with a pre-survey, 
educational flier, and then post-survey to assess their knowledge of breast cancer-related 
genetics and their emotional status.  Qualitative responses regarding cancer-related 
perceptions were also gathered post-flier.  Participants included women both affected and 
unaffected by breast cancer and were surveyed from either a Spanish-language breast 
cancer support group in Orlando, FL or a Hispanic community health education seminar 
in Charleston, SC. The Wilcoxon signed-rank test was employed to analyze pre- and 
post-flier results.  The Repeated Measures ANOVA was used to assess emotional status 
as a function of cancer diagnosis.  Qualitative data was coded and analyzed using 
grounded theory methods. Results: None of the women showed significant gains in 
knowledge related to breast cancer after viewing the educational flier. All women 
demonstrated significant increases in anxiety between baseline emotional status and 
emotional status related to either a real or hypothetical diagnosis of cancer.  Unaffected 
participants showed higher anxiety means overall.  Qualitative analysis identified four 
major themes: (1) cancer means fear, death, and family isolation; (2) cancer is difficult to 
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explain; (3) perceived causes of cancer; and (4) attitudes of hope.  Conclusions:  We 
showed that either a real or hypothetical diagnosis of breast cancer increases anxiety 
above that of baseline emotional status among our sample population of Latina women 
who attend health-focused support groups.  We theorize that a refined version of the flier 
may be more effective as part of a larger educational platform, in which participants are 
provided with expanded information and encouraged to participate in cancer and 
genetics-centered conversation. We hope future research endeavors will build upon the 
utility of effective educational materials to improve genetic counseling referrals and 
genetic-medicine healthcare among this growing population.  
2.2 Introduction 
In 2010, cancer became the leading cause of death worldwide, with breast cancer 
ranked as the most commonly diagnosed cancer among women (Neal et al., 2011; 
Phillips & Cohen, 2011).  Scientists estimate that between 5-10% of breast cancer is 
hereditary, implying that the cause of the cancer is a defective gene in the germline of an 
individual which can be passed through family generations.  Mutations within the BRCA1 
and BRCA2 genes are estimated to contribute to up to 50% of this hereditary breast 
cancer category (van der Groep, van der Wall, & van Diest, 2011; Walsh & King, 2007; 
Meindl, Ditsch, Kast, Rhiem, & Schmutzler, 2011).   For individuals carrying a BRCA1/2 
mutation, the average lifetime risk to develop breast cancer may be up to 85%, with 
additional increased risks for other cancers, including ovarian cancer (Yeomans Kinney 
et al., 2010). 
 Evidence suggests that surveillance, chemoprevention, and prophylactic surgical 
interventions are all beneficial and potentially life-saving options for individuals with 
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BRCA1/2 mutations.  The National Comprehensive Cancer Network (NCCN) states that 
high risk women would benefit from consultation with genetic counseling professionals 
in an effort to guide patient education and informed decision-making about genetic 
testing (Gammon et al., 2011).  A subset of genetic counselors specialize in the role of 
cancer genetic counseling and employ their knowledge to specifically identify those 
individuals and families at increased risk of cancer in order to promote awareness, early 
detection, and prevention (NSGC, 2013).   
Despite the recognized benefit of genetic counseling, Latino populations exhibit 
low awareness and use of genetic services. This shortcoming is striking in light of the fact 
that breast cancer is the most frequently diagnosed cancer and leading cause of cancer 
death among Latina women (Yeomans Kinney at al., 2010).  It has also been found that 
Latinas are 22% more likely to die from breast cancer within five years after diagnosis as 
compared to white women and are also more likely to be diagnosed at younger ages and 
with the disease having already progressed to later stages (Sussner et al, 2008; Yeomans 
Kinney et al., 2010).   
Importantly, Latinos are currently the fastest growing minority population in the 
United States and are predicted to comprise at least 25% of the United States population 
by the year 2050 (Yeomans Kinney et al., 2010).   At large, members of this population 
tend to confront unique cultural barriers in their access to quality medical care, including 
lack of health insurance and non-familiarity with the English language and/or Western 
medicine (Fisher, 1996; Sudarsan, Jandorf, & Erwin, 2010). With explicit regard to 
genetics, Latinos are less likely to have heard of genetic testing for cancer risk and are 
more likely to agree with perceived disadvantages of genetic testing (Sussner et al., 
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2008).  This is in spite of research that suggests that BRCA1/2 mutations account for a 
commensurate proportion of breast and ovarian cancer in these women as compared to 
non-Latina women (Gammon et al., 2011).   
Literature has also demonstrated prevalent cancer-associated stigma among Latino 
populations.  Results from a global cancer research study conducted by the 
LIVESTRONG foundation state that stigma is described as the “perception of the person 
affected by cancer as differing from the norm in a negative or undesirable way” (Neal et 
al., 2011, p. 3).  Such sentiments may subject an individual to potential discrimination, 
loss of status, rejection, and isolation (Neal et al., 2011).  The same report also showed 
that refrain from cancer-related discussions – or keeping a diagnosis secret—
consequently blocks individuals from taking risk-reducing behaviors or seeking out 
supportive services.   
Despite aforementioned healthcare barriers and cancer-related stigma, recent 
literature has suggested that Latinos maintain a high level of interest in genetic testing for 
breast cancer susceptibility (Sussner et al., 2008).  Moreover, there are demonstrated 
opportunities to capitalize upon shifting perceptions of stigmatization, in which 
communication and the dissemination of educational materials will be crucial (Neal et al., 
2011).   
Research has demonstrated the efficacy and utility of healthcare education 
materials that directly reflect cultural priorities and preferences of Latino populations 
(Sudarsan, Jandorf, & Erwin, 2010).  However, we noted an absence of data to describe 
the effect of a Latino-targeted educational module tailored specifically to genetic 
knowledge.  In order for genetic information to be meaningful and appropriately 
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disseminated, it must first be shown to effectively inform the proposed consumers. We 
hypothesized that a simple, culturally tailored educational flier would improve genetics 
knowledge as well as decrease breast cancer-related stigma among Latina women in our 
sample.  Our data measured pre- and post-flier trends in knowledge, understanding, and 
perceptions of stigmatization among this population.  We believe there is extraordinary 
value and life-saving potential in the delivery of genetic information that addresses the 
negative and undesirable perceptions of the disease.  
2.3 Materials and Methods   
 2.3.1 Participants.  The first group of participants was invited to participate from 
the Hispanic Health Initiative (HHI) Breast Cancer Support Group in Orlando, FL.  The 
meeting was conducted solely in Spanish language and assembled at MD Anderson 
hospital.  The principal investigator (PI) attended the group, introduced the project, and 
disseminated/collected the materials.   
The following was used as inclusion criteria for the HHI Orlando group:  
• Women self-described as Latina 
• Native Spanish-speakers 
The following was used as exclusion criteria for the HHI Orlando group: 
• Males 
• Non-native Spanish-speakers 
• Women who were blind (due to the nature of the materials) 
We originally intended to use “Women who had received a diagnosis of breast 
cancer during some point in their lifetime” as part of the inclusion criteria.  However, one 
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woman from HHI Orlando was found to not have been affected.  The decision was made 
to include her responses in data analysis in order to increase sample size.  
 A second group of women was invited to participate from HHI’s PASOs program in 
Charleston, SC.  The PASOs program is conducted through the Medical University of 
South Carolina and serves to optimize health among Hispanic populations through 
support and education.  These women were invited to participate in order to realize 
greater survey response and improve data analysis after all willing individuals from HHI 
Orlando were surveyed.   
 Due to travel barriers, the PI was not present during the PASOs meeting.  Detailed 
instructions were provided to the support group leader via phone, email, and written letter 
so that she might conduct the session in similar fashion.   All survey materials were 
mailed to the group leader; survey responses were collected and returned to the PI.  The 
leader of this group was a native Spanish-speaker.   
  Due to the nature of this support group, survey materials were altered to reflect 
the possibility that members of the PASOs support group had not received a personal 
diagnosis of breast cancer (see Appendices C and D).  Inclusion criteria remained the 
same. 
2.3.2 Research Methods. All disseminated materials and instructions were 
provided in Spanish language.  We presented the women with a pre-survey which 
included six questions designed to assess understanding of breast cancer genetics.  
Responses to the questions were marked as either True, False, or I Don’t Know.  The pre-
survey also included an adapted 20-item version of the State-Trait Anxiety Inventory 
(STAI) to measure baseline emotional status; the women were asked to respond to the 
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scale by reflecting on How They Feel during Most Days of the Week.   The same scale 
was presented once more on the pre-survey in order to investigate perceptions of cancer-
related anxiety/stigmatization.  The women from HHI Orlando were asked to reflect on 
How They Feel When They Think about Their Breast Cancer Diagnosis.  The women 
from PASOs Charleston were asked to reflect on How They Would Feel if they Were to 
Receive a Diagnosis of Breast Cancer.  
We then presented the women with an educational flier (one page, front-and-back) 
that served as an educational module to explain basic genetics, the genetics of breast 
cancer, and the profession of genetic counseling (see Appendix B).  The women were 
given between three to five minutes to read through the flier.  The flier was also read 
aloud by the support group leaders in order to assist participants with lower literacy 
levels.   
A post-survey was then administered.  The six questions regarding breast cancer 
genetics were re-asked in the same phrasing and order.  The same set of STAI questions 
regarding emotional status was again presented in the context of having had an actual 
diagnosis of breast cancer, or considering a hypothetical diagnosis of breast cancer. 
Generalized questions (How Do You Feel During Most Days of the Week) were excluded, 
and baseline emotional status was considered to be consistent with answers from the pre-
survey.   
We obtained qualitative data from the three open-ended questions at the end of the 
post-survey (see Appendix D).   A semi-structured interview method (see Appendix E) 
was used to collect qualitative data from those participants from Orlando willing to share 
their contact information.   Women from Charleston were not invited for follow-up phone 
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interviews due to timing of data collection.  Two follow-up interviews were conducted by 
the PI via Google Voice and recorded using Audacity software and assisted by a Spanish-
language medical interpreter.   
Pre-surveys and post-surveys were appropriately coded in order to compare and 
contrast each individual’s responses as a set.  Coding of the surveys did not include any 
of the participants’ identifying information.  All data was kept private and confidential in 
a password protected laptop.   
Those who included contact information from HHI Orlando were entered into a 
raffle to win a $25 gift card to a local restaurant or store.  All participants from PASOs 
Charleston were entered into a raffle to win 1 of 3 gift cards totaling $50.  The research 
study was approved by the Institutional Review Board of the University of South 
Carolina at Columbia, SC, in July, 2012. 
 2.3.3. Statistical Analysis.  Quantitative data was analyzed using SPSS (Statistical 
Package for the Social Sciences), version 21.0; data responses were grouped according to 
whether participants had been affected or unaffected by breast cancer due to the potential 
confounding influence of cancer diagnosis on answer selection. The Wilcoxon signed-
rank test was employed in place of the dependent t-test as a nonparame tric analysis due 
to the small sample size.  The six factual questions were analyzed both pre- and post-
educational flier to investigate changes in scores.  Emotional status responses (Baseline, 
Cancer-Related Emotional Status Pre-Educational Flier, and Cancer-Related Emotional 
Status Post-Educational Flier) were analyzed against one another to investigate potential 
differences.  Positive-emotional statements in the questionnaire were reverse coded 
during analysis to ensure consistent ranking.  
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 The Repeated Measures ANOVA test was carried out on all three emotional status 
measures to assess whether affected or unaffected group membership significantly 
affected resulting anxiety levels.    
Qualitative data was coded and analyzed using grounded-theory methods to 
investigate themes from the open-ended responses and follow-up phone interviews.  
Translation was performed by both the PI and a Spanish-English medical interpreter who 
provides services to the University of South Carolina Genetic Counseling department.  
Select quotes were included in the results section in both translated English and the 
original Spanish counterpart.  
2.4. Results 
2.4.1 Participant Demographics.  Total participants from HHI Orlando and 
PASOs Charleston equaled19 (N = 19).  Seven of eight participants from Orlando had 
received a diagnosis of breast cancer at some point during their lifetimes (affected), and 
none of the 11 participants from Charleston had received a diagnosis of breast cancer 
(unaffected).  In total, 37% (n = 7) of participants were affected and 63% (n = 12) were 
unaffected.  The unaffected group ranged in ages from 25-96, and age was not assessed in 
the Orlando group due to logistic limitations.  For those individuals with a history of 
breast cancer, year of diagnosis ranged from 1980 to 2011. All participants identified 
themselves as being Hispanic with Spanish being their native language. Respondent 
demographics are summarized in Table 2.1 and Figure 2.1.  
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Table 2.1 Participants’ Country of Origin (N = 19) 
 
HHI Orlando PASOs Charleston 
Mexico 0 9 
Colombia 3 0 
Puerto Rico 3 0 
Dominican Republic 2 0 
Peru 0 1 
Spain 0 1 
 
 
 
 
Figure 2.1 Participants’ Highest Level of Education Completed (N = 19)  
*The term “Secondary School” implies education following Elementary School.  It cannot be 
assumed to be synonymous with the United States version of High School due to substantial 
heterogeneity between countries’ educational systems. 
 
2
2
2
4
5
4
No Response
Master Degree
University/College 
Trade School or Professional Institute 
High School ("Secondary School")*
Did Not Finish High School
Participants' Highest Level of Education 
Completed
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2.4. 2 Changes in Knowledge Related to the Genetics of Breast Cancer:  
Pre- vs. Post-Educational Flier.  Participants were asked to respond to six factual 
questions before and after reviewing an educational flier.  The Wilcoxon signed-rank test 
was carried out on the responses from the group of Latina women affected by breast 
cancer (n = 7).  The results showed that genetic knowledge scores did not elicit a 
statistically significant change between pre- and post-educational flier.  Results are 
shown in Table 2.2. 
 
 
 
Table 2.2. Genetic Knowledge among Latina Women Affected by Breast Cancer, 
Measured Pre- and Post- Educational Flier (n = 7) 
 
 
Q1: About 
half of all 
breast 
cancers are 
hereditary. 
Q2: There 
is more 
than one 
gene that 
can 
increase 
the risk of 
breast 
cancer. 
Q3: All 
women 
who have a 
mutation in 
the breast 
cancer 
gene will 
get cancer. 
Q4: A 
woman 
without a 
breast 
cancer 
gene 
mutation 
can still 
develop 
breast 
cancer. 
Q5: A 
woman may 
be at 
increased 
risk of breast 
cancer if she 
has several 
close 
relatives 
with breast 
cancer. 
Q6: It’s 
possible to 
have 
several 
relatives 
with breast 
cancer by 
chance 
alone. 
Z -.966a -1.342a -.272a .000b -1.134a -1.289a 
Asymp. 
Sig. (2-
tailed) 
.334 .180 .785 1.000 .257 .197 
a. Based on positive ranks. 
b. The sum of negative ranks equals the sum of positive ranks. 
c.  Wilcoxon Signed Ranks Test; p = < .05 
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The Wilcoxon signed-rank test was also carried out on the responses of Latina 
women unaffected by breast cancer (n = 12). The results showed that genetic knowledge 
scores did not elicit a statistically significant change between pre- and post-educational 
flier. Question #2 showed a positive trend (Z = -1.913, p = .056), but was not statistically 
significant. Results are shown in Table 2.3.  
 
Table 2.3. Genetic Knowledge among Latina Women Unaffected by Breast 
Cancer, Measured Pre- and Post- Educational Flier (n = 12) 
 
Q1: About 
half of all 
breast 
cancers are 
hereditary.                                                         
Q2: 
There is 
more 
than one 
gene that 
can 
increase 
the risk 
of breast 
cancer.
Q3: All 
women 
who have 
a 
mutation 
in the 
breast 
cancer 
gene will 
get 
cancer.  
Q4: A 
woman 
without a 
breast 
cancer 
gene 
mutation 
can still 
develop 
breast 
cancer.
Q5: A 
woman 
may be at 
increased 
risk of 
breast 
cancer if 
she has 
several 
close 
relatives 
with breast 
cancer. 
Q6: It’s 
possible 
to have 
several 
relatives 
with 
breast 
cancer by 
chance 
alone.  
Z -.333a -1.913b -.812b -1.222a -.812 a -.433b 
Asymp. 
Sig. (2-
tailed) 
.739 .056 .417 .222 .417 .665 
a. Based on negative ranks. 
b. Based on positive ranks. 
c.  Wilcoxon Signed Ranks Test; p = < .05 
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2.4.3 Quantitative Analysis of Cancer-Related Anxiety.  Participants were 
asked to respond to a Likert scale questionnaire that assessed Baseline Emotional Status 
(BES), Cancer-Related Emotional Status before the educational flier (CRES-pre), and 
Cancer-Related Emotional Status after the educational flier (CRES-post).   
The Wilcoxon signed-rank test was carried out on responses from Latina women 
affected by breast cancer.  The results showed a statistically significant increase in 
anxiety between the women’s BES and CRES-pre (Z = -2.032, p = .042).  Anxiety levels 
did not show statistically significant differences between BES and CRES-post or between 
CRES-pre and CRES-post.  Results are shown in Table 2.4.   
 
 
Table 2.4. Difference in Baseline Emotional Status and Cancer-
Related Emotional Status (Pre- and Post- Educational Flier) 
Among Latina Women Affected by Breast Cancer (n = 7)  
 
 CRES-pre 
vs. BES 
CRES-post 
vs. BES 
CRES-post 
vs. CRES-
pre 
Z -2.032a -1.000a -.535b 
Asymp. Sig. (2-
tailed) .042 .317 .593 
a. Based on negative ranks. 
b. Based on positive ranks. 
c.  Wilcoxon Signed Ranks Test; p = < .05 
 
 
The Wilcoxon signed-rank test was also carried out on responses from Latina 
women unaffected by breast cancer (n = 12).  The results showed a statistically 
significant increase in anxiety between the women’s BES and CRES-pre (Z = -2.021, p = 
.028).  Results also showed a statistically significant increased anxiety between BES and 
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CRES-post, meaning post-flier anxiety remained statistically higher than that of baseline 
anxiety (Z = -2.383, p = .017). Anxiety levels did not show a statistically significant 
difference between CRES-pre and CRES-post.  Results are shown in Table 2.5.   
 
 
 
 
 The Repeated Measures ANOVA was carried out in order to analyze affected vs. 
unaffected women across all three emotional factors (BES, CRES-pre, and CRES-post).  
Results showed that levels of anxiety were dependent on whether the women were part of 
the affected or unaffected group. There was a statistically significant difference between 
the groups, F (2,7) = 4.923, p = .046.  A marginal means plot analysis demonstrates 
visually meaningful trends, including decreasing anxiety tendencies among both groups 
between CRES-pre and CRES-post as well as overall higher anxiety levels among 
unaffected participants across all three factors.  Estimated marginal means among the 
affected women also shows a clinically significant decline in CRES-post below a 
 
 
 
 
Table 2.5. Difference in Baseline Emotional Status and Cancer-
Related Emotional Status (Pre- and Post- Educational Flier) 
Among Latina Women Unaffected by Breast Cancer (n = 12)  
 
 CRES-pre 
vs. BES 
CRES-post 
vs. BES 
CRES-post 
vs. CRES-
pre 
Z -2.201a -2.383a -.210a 
Asymp. Sig. (2-
tailed) .028 .017 .833 
a. Based on negative ranks. 
b. Wilcoxon Signed Ranks Test; p = < .05 
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standardized mean of 36.5 (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983). 
Results of the Repeated Measures ANOVA are shown in Figure 2.2. 
 
 
 
 
Figure 2.2 Baseline Emotional Status vs. Cancer-Related Emotional Status Among Breast-
Cancer-Affected and Unaffected Latina Women.  
 
2.4.4 Qualitative Review of Cancer-Related Perceptions Post- Educational 
Flier.  We collected qualitative results from both written-in responses on post-surveys as 
well as phone-interview transcripts.  All women completed at least part of the written 
response section in Spanish language, and two women were able to be reached for 
follow-up phone interviews in Spanish language. After translation into English language 
by the PI and interpreter, grounded theory methods revealed four major qualitative 
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Unaffected 41.667 61.667 59.333
Affected 33.75 38.25 35.25
30
35
40
45
50
55
60
65
Es
tia
te
d 
M
a
rg
in
a
l M
e
a
n
s
Baseline Emotional Status vs. Cancer-Related Emotional Status 
Among Breast-Cancer-Affected and Unaffected Latina Women
40 
 
themes: (1) cancer means fear, death, and family isolation; (2) cancer is difficult to 
explain (“No sé”); (3) perceived causes of cancer; and (4) attitudes of hope. Examples 
are presented first in the translated English counterpart, followed by the original Spanish 
quotation. All themes include a mixture of written-in and phone-interview responses.  
Theme 1: Cancer means fear, death, and family isolation.  
The women were asked to describe “What is the first thing that comes to mind 
when you think of the word cancer?” (¿Qué es lo primero que viene a la mente cuando se 
piensa en la palabra cáncer?)  The majority of women related cancer to the following 
words: death (muerte), fear (miedo), and nerves (nervios). Three respondents expanded 
on their initial impression of cancer by writing, “That I am going to die,” (“Que me voy a 
morir”). These three women were from Charleston and had not been previously 
diagnosed with breast cancer.  
A few respondents remarked on sentiments of “being the only one diagnosed with 
cancer,” in conjunction with feelings of loneliness and/or suffering.   One respondent 
explained, “I cannot give an explanation of cancer to my family because I am the only 
one [in my family] who has suffered this sickness,” (“No puedo dar una explicación de 
cáncer en mi familia, porque yo soy la única que he sufrido esta enfermedad”).   When 
asked via phone-interview whether a participant had other family members diagnosed 
with cancer, she responded, “No…no…no…no.  Only me,” (“No…no…no…no. Yo 
solamente”). 
Notably, many women expressed concern over dying and leaving their children 
without a parent, “[I think of] death and of your children who would probably be left 
alone,” (“En la muerte. Y tus hijos que probablemente queden solos”) and, “[Cancer 
41 
 
makes me think] I am going to die and that I would leave my children alone,” (“Me voy a 
morir; voy a dejar a mis hijos solos”).  
Theme 2: Cancer is difficult to explain (“No sé”). 
Results showed a majority of written-in responses that claimed, “I don’t know” 
(No sé).  This answer was cited as a response for any of the three post-survey questions 
that were presented to the women; it was sometimes provided as an answer to all three.  
However, No sé was provided more often as an answer to the following questions (1) 
What do you think are medical causes of breast cancer? (¿Cuál cree usted que son las 
causas médicas de cáncer de mama?) and (2) How do you explain cancer in your family? 
(¿Cómo explica usted el cáncer a su familia?).  No sé was shown more often among the 
Charleston women who had not been affected by breast cancer.   
 Related to No sé, women also illustrated feelings of general confusion and being 
overwhelmed.  One woman expressed her difficulty in understanding/explaining cancer 
by claiming, “It’s difficult to explain it [cancer], given that cancer confuses everyone,” 
(“Es difícil explicarlo; puesto que todo el mundo se confudir mucho”). 
 Theme 3: Perceived causes of cancer. 
Participants discussed a number of perceived causes of cancer.  Causes were more 
often expressed in response to the question: What do you believe are non-medical causes 
of breast cancer? (¿Cuáles son las causas no-médicas de cáncer de mama?).  Causes that 
were cited most frequently included lifestyle, stress, and environment; these were often 
cited in combination.  One woman wrote: “[Breast cancer] could be influenced by poor 
nutrition, by stress or suffering,” (“Puede influir mala alimentación, por stress o 
sufrimiento”). 
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Of all mentioned causes, food/nutrition was cited most frequently.  Women 
expounded on this category to include concepts of overweight and overconsumption of 
processed foods: “The environment and some (or all) processed foods,” [“El medio 
ambiente y algunos alimentos (o todos) procesados”].   Another participant explained 
how she cautioned her family members by stating, “I have told my children that they 
need to watch their nutrition, because we can all get [be affected by] cancer,” (“Yo les he 
dicho a mis hijos que se cuiden en su alimentación, porque el cáncer nos puede llegar a 
todos”).   
A few women referenced “golpes,” or hits, as causative factors.  This term was 
referenced by Finkler (1991) and Gibbon (2011) as corresponding to a general English 
understanding of stress, or more specifically, a ‘physical blow’ that is perceived to be 
strong enough to cause cancer.    
Genes/Genetics were referenced as being cancer-causing by about one-quarter of 
participants, always under the category of non-medical causes of cancer.  Participants did 
not expand on this answer, and left responses solely as “genes” or, “changes in genes.”  
One woman wrote, “The degeneration of genes,” (“degeneración de los genes”).  
One woman whom we interviewed via phone expressed strong tones of 
religiosity.  She was the only participant to reference God and/or Christianity during the 
study.   
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 “I am very religious and believe very much in God [el Señor]… I do not 
use vices, ever.  I have always been a very conservative person in 
everything…in my eating and everything.  If God gave this [cancer] to me, 
well it’s a sign that he chose me.  Only me.  And of five sisters, this was 
given to me.  God chose me.” 
(“Porque yo soy muy cristiana, y creo mucho en el Señor … yo no uso 
vicios, nunca. Y yo siempre he sido una persona muy conservada en 
todo… para comer y para todo. Si el Señor me mandó eso, pues es seña 
que él me escogió. Yo solamente. Y de cinco hermanas que éramos, a la 
que me dio fue a mí. El Señor me escogió.”) 
Theme 4: Attitudes of hope. 
In contrast to responses of fear and/or death, a number of participants nonetheless 
expressed sentiments of positivity.  Some of these attitudes seemed to stem from internal 
predispositions to hope. 
“I think that a Good mental attitude in the face of cancer helps with curing 
(healing).  I think that a large percentage (80%) of the cure depends on us.” 
[“Pienso que con Buena actitud mental frente a la enfermidad de cancer ayuda a 
la curación (“healing”), creo que porcentaje grande (80%) de curar depende de 
nosotros.”] 
Other women credited external factors such as modern scientific medicine and the 
continuing search for treatment and cures: “Science has greatly improved and some 
cancers can be successfully treated,” (‘Que la ciencia ha adelantado mucho y algunos 
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canceres se pueden tratar con éxito’). Positive sentiments were shown more frequently 
among the Orlando group (affected) than the Charleston group (unaffected).  
Positive sentiments were shown more frequently among the HHI Orlando group 
(affected) than the PASOs Charleston group (unaffected).  It is also noteworthy that one 
woman from Orlando was the only woman to have gone through a genetic counseling 
process.  She has a known BRCA2 family mutation. She also expressed notable optimism, 
perhaps beyond that of the other women:  “Years before, it was ‘I am already dead.’ 
Now, with medical advances, I had more hope than that of my mother, aunts, and family 
members,” (“Muchos años atras fue:“estoy muerta ya.”  Ahora con los adelantos 
medicos, yo tuve mas esperanza que mi mama, tías, y familias”). 
2.5 Discussion 
 Our study demonstrated that there is significant anxiety associated with breast 
cancer among our sample population and that an educational flier may provide an 
effective tool to reduce this anxiety.  Our study purports that by measuring anxiety we 
were simultaneously assessing emotions of stigma at some level.  We believe that the 
word anxiety suggests an umbrella of stigma-related terms including “undesirable and 
negative feelings” (Neal et al., 2011, p. 3) and connotations of guilt and shame that 
therefore increase stress and cause “psychological and social morbidity” (Chapple, 
Ziebland, & McPherson, 2004, p.1).  In the publication by Chapple, Ziebland, & 
McPherson (2004), the authors interviewed 45 patients in the U.K. with lung cancer, 
many of whom remarked on the stigma associated with that disease. We believe that 
while those respondents experienced external stigma-related reactions from other people 
in many cases, the women in our study may feel stigma, including guilt and shame, 
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internally, due to their cultural norms and barriers that may prevent them from receiving 
adequate education about the true medical causes of breast cancer.    
We did show steeper increases in means anxiety among our sample of unaffected 
women (BES to CRES-pre; 41.4 to 61.7) compared with the affected group (33.8 to 
38.25).  This may have been in part due to the idea that a hypothetical diagnosis of cancer 
led to greater initial anxiety, which may have caused the steeper initial rise in anxiety.  In 
other words, these women had not already contended with and accustomed themselves to 
cancer-associated stress.  We also acknowledge that their health seminar was not tied 
directly to breast cancer and that the survey theme was therefore a surprising – and 
potentially anxiety-producing – topic.  This idea of an unannounced cancer survey may 
also account for their higher levels of anxiety overall, including baseline status.  
We recognize that that not all variables could be controlled for during the study, 
including those that may have contributed to declining means in anxiety post-educational 
flier, therefore falsely inflating the weight of the educational intervention.  Other 
mechanisms for decreases in anxiety could have included general alleviation of anxiety 
over the course of the group session, greater sense of comfort after talking and interacting 
with other group members, or heightened positive emotions related to finishing the 
survey.   
We did not show significant gains in knowledge of genetics related to breast cancer.  
It is possible that this could simply be a function of small sample size or of insufficient 
time to absorb the flier’s information. However, we also consider that the study design 
likely underestimated the complexity of the questions and the validity of the answers in 
the context of the lower literacy levels among at least some of the women.  In future 
46 
 
studies, we would propose that the questions be back-translated and validated via a pilot 
study to assess participant comprehension of the statements.  We additionally consider 
that the women may have experienced survey fatigue after reviewing the flier and were 
therefore less motivated to answer the questions correctly.   
We point out that Question #2 demonstrated a positive trend among the unaffected 
women, meaning that although it was not statistically significant, a larger sample size 
may have achieved statistical significance for increased level of genetic knowledge.  
Question #2 stated that There is more than one gene that can increase the risk of breast 
cancer, and the answer is true.  The educational flier was specifically designed to 
communicate that both the BRCA1 and BRCA2 genes can contribute to hereditary breast 
cancer.  There are, of course, other known genes but they were not mentioned as part of 
the study.  We suggest that this question was more easily answerable due to the repetition 
of BRCA1 and BRCA2 (written twice) and the plurality of the word ‘genes’ on the 
educational flier.  This aligned with conclusions from the 2004 study by Rosal et al. 
which found that educational preferences of Latinos included repetitive and succinct 
messages.  
Analysis of qualitative data cannot be framed against pre-educational flier sentiments, 
as this information was only gathered from the post-survey and follow-up phone 
interviews.  Nonetheless, the voices provide context for further education and interaction 
among Latina women regarding breast cancer. While the educational flier seemed to have 
decreased anxiety means in our sample population, we recommend that its 
implementation may be more effective as part of a larger educational platform.  For 
instance, the flier might be disseminated as part of an invitation for a health education 
47 
 
seminar where actual seminar conversations could include expanded education along 
with talking-points that address qualitative findings.  
We found that more positive and optimistic statements were provided among the 
affected HHI Orlando group than the unaffected PASOs Charleston group.  These 
positive statements included the hopefulness conveyed by the BRCA+ participant. 
Regarding this group as a whole, it is not unlikely that having survived breast cancer 
rendered these women less likely to remark on the absoluteness of death from cancer. 
The unaffected PASOs Charleston group also provided more responses of I don’t 
know to the open-ended questions at the end of the survey. This demonstrates that 
confusion and not-knowing persisted beyond distribution of the educational flier and 
reinforces our finding that women did not improve knowledge scores related to breast 
cancer genetics. Because the majority of I don’t know responses were provided by 
unaffected participants, we suggest that the women affected with breast cancer had 
received at least some helpful medical or psychological information during their 
diagnosis and/or treatment. Given this supposition, we suggest that breast cancer related 
materials could be especially useful as educational tools for preventive interventions 
during educational seminars directed towards all Latina women, not just those who have 
been affected by cancer.   
We theorize that affected women were less likely to have responded I don’t know due 
to having gone through a personal diagnosis of breast cancer.  However, they were 
certainly not immune from emotions of confusion and/or devastation.  Support groups 
and educational interventions might be able to target more detailed subjects among these 
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women, such as deeper understanding of emotions of grief and shame as well as better 
understanding of perceived barriers to genetic counseling (Sussner et al., 2012).  
Only about one-quarter of participants referenced genes/genetics as cancer-causing 
variables.  This finding seems to be consistent with literature showing that minority 
populations have limited knowledge about genetics (Gammon et al., 2010; Gibbon, 2011; 
Catz et al., 2005).  We also noted that genetics was referenced as a non-medical cause of 
cancer, while food/nutrition/stress was cited more frequently as being a medical cause of 
cancer. We similarly propose that genetics was provided under the umbrella of non-
medical causes of cancer as a result of participants being less familiar with genetics, 
therefore perceiving it as “less medical.” In addition, as described by Peterson-Iyer 
(2008), Latinos who are more inclined to rely on non-Western doctors are more likely to 
approach illness as form of sickness, rather than a disease in a purely biomedical sense.   
Importantly, we did not measure the women’s understanding of the availability of 
genetic testing.  Gammon et al. (2011) discussed that lower levels of BRCA1/2 testing 
awareness among minority groups in the United States demonstrates a need for all at-risk 
individuals to be better informed about its availability.  In our sample population, only 
one woman had gone through genetic counseling and was known to be a BRCA mutation 
carrier.  This woman was opportunely prompted by the nature of the study to speak up 
and share her experience with the other support group members.  It is plausible that her 
experience spread awareness and shed favorable light on the opportunity and availability 
of genetic counseling and testing.  This case attests to a potential outlet for willing Latina 
women who have already gone through the genetic counseling/testing process to conduct 
personal community outreach and story-telling.  This concept builds upon the research by 
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Sudarsan, Jandorf, & Erwin (2010) who maintained that determinants of health be 
addressed through “social networks, neighborhoods, and communities” (p. 194).  
 2.5.1. Limitations.  Our study analyzed the data of a relatively small sample 
population from two United States locations, representing six countries of origin.  All 
materials were developed by the PI who is not Latina and for whom Spanish is not her 
native language.  It is conceivable that participants from HHI Orlando were less 
motivated to participate in the study with knowledge that the PI was not of Latina 
ancestry.  In addition, the PI has no way of knowing the exact details of data collection 
from PASOs Charleston, as she was not present. 
 2.5.2 Areas for future research.  As of result of small sample size, we were unable 
to tease out significant variables that have been shown to affect health strategies among 
Latinos.  Future studies might investigate how country of origin, age, and level of 
acculturation alters improvements in genetics knowledge and levels of anxiety/stigma 
(Cokkinides et al., 2012). We also acknowledge that our demonstrated increases in 
anxiety related to cancer (BES to CRES-pre) may not be unique to Latina women.  
Indeed, heighted anxiety may likely represent a universal and general response to the idea 
of cancer. However, follow-up studies could investigate the degree of heightened anxiety 
related to cancer as compared between different ethnicities.   
 Our study did not originally intend to survey women unaffected by breast cancer; 
however our results showed statistically significant differences in anxiety between our 
affected and unaffected groups of participants.  Future endeavors might explore how to 
better stratify educational materials for Latina women according to diagnosis status in 
order to achieve more significant decreases in post-flier anxiety. 
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 In addition, we chose to create our educational intervention using a simple paper flier 
due to its cost-effectiveness, efficiency, and ability to reach larger populations, 
particularly those without multi-media access.  However, we recognize that illiteracy and 
disinterest in reading “educational material” limits the potential effectiveness of our tool 
and we would therefore be interested in the influence of other modalities that have shown 
to be effective and preferred among Latino populations.  These modalities might include 
entertainment forms of education such as telenovelas, radio, and magazine (Yeomans 
Kinney et al., 2010; Cokkinides et al., 2012). 
 It might also be worthwhile for genetic counselors to propagate information by 
attending meetings and giving presentations to oncologists, surgeons, primary care 
physicians, and gynecologists who are Spanish-speaking and involved in serving the 
Latino community.  This concept was initially proposed by Rolnick et al. (2011) to 
reduce patient barriers to genetic testing, and was also addressed in literature by Escarce 
& Kapur (2006), stating that Latinos are hindered in their ability to obtain healthcare 
services due to their own limited English proficiency and the limited Spanish proficiency 
of healthcare providers.  This vehicle of information distribution (via Spanish-speaking 
doctors or nurses) also prioritizes and emphasizes the need to add more Spanish-speaking 
medical providers to the Unites States healthcare system as the Latino population grows. 
2.6 Conclusions 
We believe that the potential to reduce cancer-related stigma combined with 
enhanced knowledge of genetics among Latinas is an important step in closing in on 
genetic health service gaps.  It is well documented that there is value in providing both 
genetics education as well as education that addresses the negative and undesirable 
51 
 
perceptions of disease.  These combined factors can therefore empower Latina women to 
overcome fear and combat cancer-associated morbidity, as well as share valuable and 
life-saving information with family members. 
The participants in our study represented Latina women who were both affected and 
unaffected by breast cancer.  The sample size was small, but we showed significant 
increases in anxiety (above baseline emotional status) in response to either a real or 
hypothetical diagnosis of breast cancer among our participants.   Unaffected participants 
demonstrated higher anxiety means overall, and both unaffected and affected participants 
demonstrated some decrease in mean anxiety between pre- and post-educational flier, 
when analyzed as distinct groups.   
Participants in our study did not show improvements in genetic knowledge related to 
breast cancer after the educational flier intervention.  This may have been a function of 
small sample size, complexity of information, poor English to Spanish translation, or 
inadequate time to process the information in the flier.  This study chose to use a simple 
paper flier due to its cost-effectiveness, efficiency, and ability to reach larger populations, 
particularly those without multi-media access.  However, further refinement of the flier 
and its presentation of delivery may be necessary in order to improve its effect.  We also 
acknowledge that there is room to explore alternative methods of flier distribution along 
with other outlets of education, including television and radio.   However, we remind 
future researchers that many members of this population do not have access to multi-
media equipment, and are consequently limited in where and how they receive genetic 
health information (Livingston, 2010).   
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Our hope is that future research endeavors will build upon the utility of effective 
educational tools that address genetics education among Latino populations, with the 
intention to achieve an equitable balance between genetic medicine, identity, and health 
status.  Such endeavors thus align with the United States Department of Health and 
Humans Service’s overall health objectives for the year 2020 which includes the goal to 
“Improve health and prevent harm through valid and useful genomic tools in clinical and 
public health practices” (Healthy People, 2012).  To move forward in this sense – 
specifically with regard to health goals among Latino populations in the United States– 
culturally tailored information must be provided that addresses their most compelling 
barriers and enhances access to healthcare services, including genetic counseling.  
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Chapter 3. Conclusions
We believe that the potential to reduce cancer-related stigma combined with 
enhanced knowledge of genetics among Latinas is an important step in closing in on 
genetic health service gaps.  It is well documented that there is value in providing both 
genetics education as well as education that addresses the negative and undesirable 
perceptions of disease.  These combined factors can therefore empower Latina women to 
overcome fear and combat cancer-associated morbidity, as well as share valuable and 
life-saving information with family members. 
The participants in our study represented Latina women who were both affected and 
unaffected by breast cancer.  The sample size was small, but we showed significant 
increases in anxiety (above baseline emotional status) in response to either a real or 
hypothetical diagnosis of breast cancer among our participants.   Unaffected participants 
demonstrated higher anxiety means overall, and both unaffected and affected participants 
demonstrated some decrease in mean anxiety between pre- and post-educational flier, 
when analyzed as distinct groups.   
Participants in our study did not show improvements in genetic knowledge related to 
breast cancer after the educational flier intervention.  This may have been a function of 
small sample size, complexity of information, poor English to Spanish translation, or 
inadequate time to process the information in the flier.  This study chose to use a simple 
paper flier due to its cost-effectiveness, efficiency, and ability to reach larger populations, 
particularly those without multi-media access.  However, further refinement of the flier 
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and its presentation of delivery may be necessary in order to improve its effect.  We also 
acknowledge that there is room to explore alternative methods of flier distribution along 
with other outlets of education, including television and radio.   However, we remind 
future researchers that many members of this population do not have access to multi-
media equipment, and are consequently limited in where and how they receive genetic 
health information (Livingston, 2010).   
Our hope is that future research endeavors will build upon the utility of effective 
educational tools that address genetics education among Latino populations, with the 
intention to achieve an equitable balance between genetic medicine, identity, and health 
status.  Such endeavors thus align with the United States Department of Health and 
Humans Service’s overall health objectives for the year 2020 which includes the goal to 
“Improve health and prevent harm through valid and useful genomic tools in clinical and 
public health practices” (Healthy People, 2012).  To move forward in this sense – 
specifically with regard to health goals among Latino populations in the United States– 
culturally tailored information must be provided that addresses their most compelling 
barriers and enhances access to healthcare services, including genetic counseling.  
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Appendices 
Appendix A: Survey Invitation 
 
HHI Orlando Participants (English and Spanish Versions) 
 
Dear Potential Participant: 
 
You are invited to participate in a graduate research study focusing on breast cancer 
among Latina women.  I am a graduate student in the genetic counseling program at the 
University of South Carolina School of Medicine.  My research investigates the 
perceptions of cancer and of genetic knowledge of Latina women diagnosed with breast 
cancer.  The research involves reviewing an associated flier about breast cancer and 
genetics, and completing two surveys. 
 
The surveys attempt to interpret your understanding of genetics information and 
viewpoints regarding cancer before and after having looked at the flier.  If you do not 
wish to answer a certain question, please skip that question and continue with the rest of 
the survey. 
 
All responses gathered from the surveys will be kept anonymous and confidential.  We 
only ask for your name and phone number in the event that you are interested in 
providing more information at a later date over the phone.   It is not necessary that you 
provide this information.  The results of this study might be published or presented at 
academic meetings; however, participants will not be identified. 
 
Participants who include contact information will also be entered into a raffle to win a 
$25 gift card to a local restaurant or store. If you are chosen, this prize will be sent to you 
at a later date, after having collected all data.  Your contact information will not be used 
for any other purposes beyond a follow-up phone interview or to send you the raffle prize 
if you have won. 
 
Your participation in this research is voluntary.  By completing the survey, you are 
consenting that you have read and understand this information.  At any time, you may 
withdraw from the study by not completing the survey. 
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Thank you for your time and consideration to participate in this survey.   Your responses 
may help genetic counselors create more helpful education materials for Latina women.  
If you have any questions regarding this research, you may contact either myself or my 
faculty adviser, Peggy Walker, MS, CGC, using the contact information below.  If you 
have any questions about your rights as a research participant, you may contact the Office 
of Research Compliance at the University of South Carolina at (803)777-7095. 
 
Sincerely,  
 
Jade Cognetti, B.S., B.A.   
Genetic Counselor Candidate 
University of South Carolina School of Medicine     
USC Genetic Counseling Program  
Jade.cognetti@gmail.com 
(321)662-6889 
 
Peggy Walker, MS, CGC 
Faculty Adviser 
University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 208 
Columbia, SC 29203 
Peggy.Walker@uscmed.sc.edu  
(803) 545-5746 
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Estimado Participante Potencial:  
 
Usted está invitada a participar en un estudio de investigación de posgrado centrado en el 
cáncer de mama en las mujeres latinas. Soy un estudiante de posgrado en el programa de 
consejo genético en la Universidad de South Carolina, Facultad de Medicina. Mi 
investigación se trata de las percepciones de cáncer y del conocimiento genético de las 
mujeres latinas diagnosticadas con cáncer de mama. Esta investigación involucre un 
folleto sobre el cáncer de mama y la genética, y responder dos encuestas al respect.  
 
Hay dos encuestas que tratan de interpretar su comprensión de la información genética y 
puntos de vista sobre el cáncer antes y después de haber mirado el folleto. Si usted no 
desea responder a una pregunta determinada, por favor salte esa pregunta y continúe con 
el resto de la encuesta. 
 
Todas las respuestas obtenidas de las encuestas serán anónimas y confidenciales. Sólo le 
pedimos su nombre y número de teléfono en el caso de que usted esté interesada en 
proporcionar más información en una fecha posterior a través del teléfono. No es 
necesario que proporcione esta información. Los resultados de este estudio podrían ser 
publicados o presentados en congresos académicos, sin embargo, las participantes no 
serán identificadas. 
 
Los participantes que incluyen información de contacto también serán entradas en una 
rifa para ganar una tarjeta de regalo de $ 25 a un restaurante o tienda local.  Si usted es 
elegida, este premio será enviado a usted en una fecha posterior, después de haber 
recogido todos los datos. Su información de contacto no será utilizada para ningún otro 
propósito más allá de una entrevista telefónica o para enviarle el premio de la rifa si ha 
ganado. 
 
Su participación en esta investigación es voluntaria. El completar la encuesta implica que 
usted ha leído y comprendido esta información. En cualquier momento, usted puede 
retirarse del estudio al no completar la encuesta. 
 
Gracias por su tiempo y consideración a participar en esta encuesta.  Sus respuestas 
pueden ayudar a los consejeros genéticos a crear materiales educativos más útiles para las 
mujeres latinas.  Si usted tiene alguna pregunta relacionada con esta investigación, puede 
ponerse en contacto conmigo o con mi asesor académico, Peggy Walker, M.S.G.C, 
utilizando la información de contacto a continuación. Si usted tiene alguna pregunta 
acerca de sus derechos como participante en la investigación, puede comunicarse con la 
Oficina de Cumplimiento de Investigación de la Universidad de South Carolina al (803) 
777-7095. 
 
 
 
 
 
 
64 
 
Gracias,  
 
Jade Cognetti, B.S., B.A.   
Genetic Counselor Candidate 
University of South Carolina School of Medicine     
USC Genetic Counseling Program  
Jade.cognetti@gmail.com 
(321)662-6889 
 
Peggy Walker, MS, CGC 
Faculty Adviser 
University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 208 
Columbia, SC 29203 
Peggy.Walker@uscmed.sc.edu  
(803) 545-5746 
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PASOS Charleston Participants (English and Spanish Versions) 
 
Dear Potential Participant: 
 
You are invited to participate in a graduate research study focusing on breast cancer 
among Latina women.  I am a graduate student in the genetic counseling program at the 
University of South Carolina School of Medicine.  My research investigates the 
perceptions of cancer and of genetic knowledge of Latina women.  The research involves 
reviewing an associated flier about breast cancer and genetics, and completing two 
surveys. 
 
The surveys attempt to interpret your understanding of genetics information and 
viewpoints regarding cancer before and after having looked at the flier.  If you do not 
wish to answer a certain question, please skip that question and continue with the rest of 
the survey. 
 
All responses gathered from the surveys will be kept anonymous and confidential.  The 
results of this study might be published or presented at academic meetings; however, 
participants will not be identified. 
 
As incentive, participants will be entered into a raffle to win a $20-$30 gift card to Wal-
Mart. If you are chosen, this prize will be given to you on this date. 
 
Your participation in this research is voluntary.  By completing the survey, you are 
consenting that you have read and understand this information.  At any time, you may 
withdraw from the study by not completing the survey. 
 
Thank you for your time and consideration to participate in this survey.   Your responses 
may help genetic counselors create more helpful education materials for Latina women.  
If you have any questions regarding this research, you may contact either myself or my 
faculty adviser, Peggy Walker, MS, CGC, using the contact information below.  If you 
have any questions about your rights as a research participant, you may contact the Office 
of Research Compliance at the University of South Carolina at (803)777-7095. 
 
Sincerely,  
 
Jade Cognetti, B.S., B.A.   
Genetic Counselor Candidate 
University of South Carolina School of 
Medicine     
USC Genetic Counseling Program  
Jade.cognetti@gmail.com 
(321)662-6889 
 
 
Peggy Walker, MS, CGC 
Faculty Adviser 
University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 208 
Columbia, SC 29203 
Peggy.Walker@uscmed.sc.edu  
(803) 545-5746 
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Estimada Participante Potencial:  
 
Usted está invitada a participar en un estudio de investigación de posgrado centrado en el 
cáncer de mama en las mujeres latinas. Soy un estudiante de posgrado en el programa de 
consejo genético en la Universidad de South Carolina, Facultad de Medicina. Mi 
investigación se trata de las percepciones de cáncer y del conocimiento genético de las 
mujeres latinas. Esta investigación involucre un folleto sobre el cáncer de mama y la 
genética, y responder dos encuestas al respect.  
 
Hay dos encuestas que tratan de interpretar su comprensión de la información genética y 
puntos de vista sobre el cáncer antes y después de haber mirado el folleto. Si usted no 
desea responder a una pregunta determinada, por favor salte esa pregunta y continúe con 
el resto de la encuesta. 
 
Todas las respuestas obtenidas de las encuestas serán anónimas y confidenciales. Los 
resultados de este estudio podrían ser publicados o presentados en congresos académicos, 
sin embargo, las participantes no serán identificadas. 
 
Como incentivo, las participantes entrarán en un sorteo para ganar una tarjeta de regalo 
para Wal-Mart, en el valor de $20-$30. Si usted es elegida, este premio será entregado a 
usted en esta fecha.   
 
Su participación en esta investigación es voluntaria. El completar la encuesta implica que 
usted ha leído y comprendido esta información. En cualquier momento, usted puede 
retirarse del estudio al no completar la encuesta. 
 
Gracias por su tiempo y consideración a participar en esta encuesta.  Sus respuestas 
pueden ayudar a los consejeros genéticos a crear materiales educativos más útiles para las 
mujeres latinas.  Si usted tiene alguna pregunta relacionada con esta investigación, puede 
ponerse en contacto conmigo o con mi asesor académico, Peggy Walker, M.S.G.C, 
utilizando la información de contacto a continuación. Si usted tiene alguna pregunta 
acerca de sus derechos como participante en la investigación, puede comunicarse con la 
Oficina de Cumplimiento de Investigación de la Universidad de South Carolina al (803) 
777-7095. 
 
Gracias,  
 
Jade Cognetti, B.S., B.A.   
Genetic Counselor Candidate 
University of South Carolina School of 
Medicine     
USC Genetic Counseling Program  
Jade.cognetti@gmail.com 
(321)662-6889 
 
 
Peggy Walker, MS, CGC 
Faculty Adviser 
University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 208 
Columbia, SC 29203 
Peggy.Walker@uscmed.sc.edu  
(803) 545-5746 
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Appendix B: Educational Flier 
 
 (English Version; front and back) 
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(Spanish Version; front and back) 
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Appendix C: Participant Pre-Surveys 
HHI Orlando (Pre-Survey, English) 
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HHI Orlando (Pre-Survey, Spanish) 
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PASOs Charleston (Pre-Survey, English)  
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PASOs Charleston (Pre-Survey, Spanish) 
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Appendix D: Participant Post-Surveys 
 
HHI Orlando (Post-Survey, English) 
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HHI Orlando (Post-Survey, Spanish) 
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PASOs Charleston (Post-Survey, English) 
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PASOs Charleston (Post-Survey, Spanish) 
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Appendix E: Semi-Structured Interview Questions 
English: 
You are being asked to participate in this phone interview because you filled in your 
contact information on the post-survey that investigated perceptions of cancer and of 
genetic knowledge of Latina women diagnosed with breast cancer.  This survey was 
conducted on ___ date at ___ support group. This phone interview aims to investigate 
those perceptions in more depth.  This interview is voluntary and should not take 
more than 30 minutes.  The study is conducted by Jade Cognetti, a graduate student 
in genetic counseling at the University of South Carolina.  Please note that this 
interview will be recorded. All of your responses will be anonymous, and your 
personal information will not be given out.   If you have any questions, please contact 
Jade Cognetti or her faculty adviser, Peggy Walker, MS, CGC. 
 
Jade Cognetti, B.S., B.A.   
Genetic Counselor Candidate 
University of South Carolina School of Medicine 
USC Genetic Counseling Program  
Two Medical Park, Suite 208 
Columbia, SC 29203 
Jade.cognetti@gmail.com 
(321)662-6889  
 
Peggy Walker, MS, CGC 
Faculty Adviser 
University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 208 
Columbia, SC 29203 
Peggy.Walker@uscmed.sc.edu  
(803) 545-5746
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On the survey, you described cancer as [….].  What else you would like to add to 
that description? 
On the survey, you described medical causes of cancer as […].  What else you would 
like to add? 
What are your reasons for believing that? Where did you first hear that information? 
On the survey, you described non-medical causes of cancer as […].  What else you 
would like to add? 
What are your reasons for believing that?? Where did you first hear that information? 
On the survey, you wrote how you explained your diagnosis to your family as […].  
What else you would like to add? 
What was your family’s response? 
Did you feel strongly supported? Why or why not? 
What opinions did your family have about the cause of the diagnosis? How were these 
opinions different than yours? 
Did you find the educational flier helpful? 
Why or why not? 
What was confusing about the flier? 
What information was the most useful? 
What improvements would you recommend? 
What else you would like us to know about your perceptions of breast cancer or 
your experience with this research? 
Thank you for your time.  
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Spanish: 
Usted está invitada a participar en esta entrevista telefónica debido al hecho de que 
usted ha dado su información de contacto en el post-encuesta que investigó las 
percepciones de cáncer y del conocimiento genético de las mujeres latinas 
diagnosticadas con cáncer de mama. Esta encuesta tomó lugar en ____ por la fecha 
_______. Esta entrevista telefónica tiene como objetivo investigar las percepciones en 
más profundidad. Esta entrevista es voluntaria y no debe tardar más de 30 minutos. El 
estudio es realizado por Jade Cognetti, una estudiante graduada en el Consejero  
Genético en la Universidad de South Carolina.  Por favor, tenga en cuenta que esta 
entrevista será grabada.  Todas sus respuestas serán anónimas, y su información 
personal no será compartida.  Si usted tiene alguna pregunta, póngase en contacto con 
Jade Cognetti o su asesor académico, Peggy Walker, MS, CGC. 
 
Jade Cognetti, B.S., B.A.   
Genetic Counselor Candidate 
University of South Carolina School of Medicine 
USC Genetic Counseling Program  
Two Medical Park, Suite 208 
Columbia, SC 29203 
Jade.cognetti@gmail.com 
(321)662-6889  
 
Peggy Walker, MS, CGC 
Faculty Adviser 
University of South Carolina School of 
Medicine 
USC Genetic Counseling Program 
Two Medical Park, Suite 208 
Columbia, SC 29203 
Peggy.Walker@uscmed.sc.edu  
(803) 545-5746 
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En la encuesta, usted ha descrito el cáncer como [....]. ¿Qué más le gustaría añadir a 
esta descripción? 
En la encuesta, usted ha descrito las causas médicas de cáncer como [...]. ¿Qué más 
le gustaría agregar? 
¿Cuáles son sus razones para creer eso? Cuando se enteró de esta información? 
En la encuesta, usted ha descrito las causas no médicas de cáncer como [...]. ¿Qué 
más le gustaría agregar? 
¿Cuáles son sus razones para creer eso? Cuando se enteró de esta información? 
En la encuesta, escribió cómo se explica su diagnóstico a su familia [...]. ¿Qué más le 
gustaría agregar? 
¿cómo reacciona su familia? 
¿Se sintió que tenía bastante apoyo (emocional)? ¿Por qué o por qué no? 
¿Qué opiniones le tienen a su familia acerca de la causa del diagnóstico? ¿Cómo fueron 
esas opiniones diferentes a la suya? 
¿Le ha resultado útil el folleto educativo? 
¿Por qué o por qué no? 
¿Lo que se presta a confusión sobre el folleto? 
¿Qué información es la más útil? 
¿Qué mejoras recomendaría usted? 
¿Qué más le gustaría que sepamos acerca de sus percepciones de cáncer de mama o 
de su experiencia con esta investigación? 
Gracias por su tiempo. 
 
 
